Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$8.41 – $19.20
0% from low
Exchange
OTC Link
OS
DAI NIPPON PHARM ORD
No one on the platform currently holds DNPUF.
No tracked institution reports a position in DNPUF as of their last filing.
No one on the platform has traded DNPUF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $565.7B | +26.0% | $204.69 | $193.89–$216.46 | 0.0× | 1 |
| 2028 | $614.3B | +8.6% | $199.58 | $189.05–$211.06 | 0.0× | 1 |
| 2029 | $626.8B | +2.0% | $153.72 | $145.61–$162.56 | 0.1× | 1 |
| 2030 | $687.0B | +9.6% | $239.71 | $227.06–$253.50 | 0.0× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $0.12 | $0.24 | +104.0% |
| 2026-05-13 | $-0.10 | $-0.01 | +86.6% |
| 2026-01-30 | $-0.01 | $0.14 | +2651.4% |
| 2025-10-31 | $0.53 | $1.49 | +179.0% |
| 2025-07-31 | $0.14 | $0.20 | +43.1% |
| 2025-05-13 | $-0.08 | $0.04 | +149.4% |
| 2025-01-31 | $0.26 | $0.86 | +225.5% |
| 2024-10-30 | $0.12 |
| $-0.84 |
| -775.8% |
| $5.9B |
| — |
| LVZPFLivzon Pharmaceutical Group Inc. | $5.22 | +0.00% | $6.1B | — |
| SGFEFSiegfried Holding AG | $84.12 | +0.00% | $3.7B | — |
Source: Financial Modeling Prep · peers by sector/industry